Holdings
Samsara Biocapital, LLC
As of Jun 30, 2026, Samsara Biocapital, LLC reported 23 positions worth US$1.21B. Largest: Scholar Rock Holding Corporation, Alumis Inc. and Mineralys Therapeutics, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Scholar Rock Holding Corporation | 6.9M | US$379M | no change | Jun 30, 2026 |
| Alumis Inc. | 6.35M | US$179M | no change | Jun 30, 2026 |
| Mineralys Therapeutics, Inc. | 5.87M | US$158M | no change | Jun 30, 2026 |
| Septerna, Inc. | 3.15M | US$105M | no change | Jun 30, 2026 |
| Alamar Biosciences, Inc. | 2.48M | US$67.2M | new | Jun 30, 2026 |
| Neurogene Inc. | 1.72M | US$54M | no change | Jun 30, 2026 |
| Kalaris Therapeutics, Inc. | 12.9M | US$52.4M | −66,906 | Jun 30, 2026 |
| Spyglass Pharma, Inc. | 2.11M | US$47M | no change | Jun 30, 2026 |
| Sutro Biopharma, Inc. | 1.06M | US$35.3M | no change | Jun 30, 2026 |
| Inventiva Sa | 6.31M | US$23.9M | +1.12M | Jun 30, 2026 |